On or around 07/01/2020 (Date of last review)
Filing Date: June 26, 2020
According to the Complaint, resTORbio, Inc. is a clinical-stage biopharmaceutical company that develops innovative medicines that target the biology of aging to treat aging-related diseases.
On April 28, 2020, resTORbio, Inc.’s Board of Directors caused resTORbio to enter into an agreement and plan of merger with Adicet Bio, Inc. Upon the closing of the Proposed Transaction, stockholders of Adicet are expected to own approximately 75% of the outstanding common stock of resTORbio, while shareholders of resTORbio are expected to own approximately 25%.
On June 23, 2020, Defendants filed a Form S-4 Registration Statement with the United States Securities and Exchange Commission, which recommends that the Company’s stockholders vote to approve, among other things, the issuance of stock in connection with the Proposed Transaction. The Complaint alleges that the Registration Statement omits material information with respect to the Proposed Transaction, which renders the Registration Statement false and misleading.
Company & Securities Information
Defendant: resTORbio, Inc.
Industry: Biotechnology & Drugs
Headquarters: United States
Ticker Symbol: TORC
Company Market: NASDAQ
Market Status: Public (Listed)
About the Company & Securities Data
"Company" information provides the industry and sector classification and headquarters state for the primary company-defendant in the litigation. In general, "Securities" information provides the ticker symbol, market, and market status for the underlying securities at issue in the litigation.
In most cases, the primary company-defendant actually issued the securities that are the subject of the litigation, and the securities information and company information relate to the same entity. In a small subset of cases, however, the primary company-defendant is not the issuer (for example, cases against third party brokers/dealers), and the securities information and company information do not relate to the same entity.
First Identified Complaint
Patrick Plumley, et al. v. resTORbio, Inc., et al.
COURT: D. Delaware
DOCKET #: 20-CV-00858
JUDGE: Hon. Maryellen Noreika
DATE FILED: 06/26/2020
CLASS PERIOD START: 04/29/2020
CLASS PERIOD END: 06/26/2020
PLAINTIFF FIRMS NAMED IN COMPLAINT:
Rigrodsky & Long, P.A. (Wilmington)
RM Law, P.C. (Berwyn)
First Identified Complaint (FIC) Filings:
Complaint for Violation of the Securities Exchange Act of 1934
U.S. District Court Civil Docket
—Reference Complaint Complaint Related Data is not available
Related District Court Filings
—Related District Court Filings Data is not available